1992;41:912 919. 205. Bakris GL, Slataper R, Vicknair N, et al. ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects. J Diabetes Complications. 1994;8:2 6. 206. Bojestig M, Karlberg BE, Lindstrom T, et al. Reduction of ACE activity is insuf cient to decrease microalbuminuria in normotensive patients with type 1 diabetes. Diabetes Care. 2001;24:919 924. 207. Capek M, Schnack C, Ludvik B, et al. Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study. Clin Investig. 1994;72:961 966. 208. Chase HP, Garg SK, Harris S, et al. Angiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects: a two- year trial. Ann Ophthalmol. 1993;25:284 289. 209. Cordonnier DJ, Pinel N, Barro C, et al. Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies Group. J Am Soc Nephrol. 1999;10: 1253 1263. 210. Crepaldi G, Carta Q, Deferrari G, et al. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. Diabetes Care. 1998;21:104 110. 211. Garg SK, Chase HP, Jackson WE, et al. Renal and retinal changes after treatment with ramipril and pentoxifyline in subjects with IDDM. Ann Ophthalmol Glaucoma. 1998;30:33 37. 212. Hommel E, Jensen B, Parving H. Long-term effect of captopril on kidney function in normotensive insulin dependent diabetic patients (iddm) with diabetic nephropathy [abstract]. J Am Soc Nephrol. 1995;6:450. 213. Katayama S, Kikkawa R, Isogai S, et al. Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM). Diabetes Res Clin Pract. 2002;55:113 121. 214. Laffel LM, McGill JB, Gans DJ. 